Research & Development
Immune System Diseases: Page 3
Hematology thrives with decentralized approaches
The basis of hematology testing is the complete blood count (CBC), which provides information on blood components: hemoglobin, hematocrit, red blood cells, white blood cells, reticulocytes, and platelets. The CBC is run as part of the normal workup in an annual health exam and for every inpatient. A drop of blood is placed on a microscope slide and stained. The slide is then examined under a microscope and the cells are analyzed.
November 20, 2019
Blood-based biomarkers home in on PTSD in war zone veterans
For the study, the investigators examined war zone-exposed veterans of the Iraq and Afghanistan conflicts who had confirmed PTSD, as well as war zone-deployed veterans as healthy controls. The subjects were recruited from New York City-based Veterans Affairs (VA) medical centers and from other regional VA medical centers, veterans' service organizations, and the general community.
September 16, 2019
Babesiosis testing makes strides with FDA clearances
Ticks are arachnids: Small crawling bugs with eight legs that are related to spiders and mites. They are also parasites and feed on the blood of humans and animals. Ticks are vectors due to their disease transmission capability.
May 14, 2019
Microfluidic device could detect Ebola virus earlier
Developed by researcher Ke Du, PhD, at the Rochester Institute of Technology, the device uses clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing technology to monitor and detect RNA markers for Ebola, a highly contagious virus for which there are limited treatments. Individuals in areas where Ebola infections are common are often required to take a blood test before they can travel.
May 5, 2019
Kalorama's notable product launches for clinical labs in Q1 2019
In the POC segment, one of the breakthrough approvals from the U.S. Food and Drug Administration (FDA) was for the Sangia total prostate-specific antigen (PSA) test by Opko Health (Woburn, MA) in January. The Sangia test is the first POC test that quantitatively measures total PSA in capillary whole blood, and it is approved for use with the digital rectal exam (DRE) to screen for prostate cancer in men 50 years and older. The test can be administered with a finger prick and results are generated in 12 minutes.
April 24, 2019
Labs gear up to diagnose novel fungal infection
In the past few years, more than 600 cases of an emerging fungal infection called Candida auris have been identified in 12 U.S. states, according to the CDC.
April 14, 2019
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Page 3 of 3